Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Garajová

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Cancers|January 8, 2025
Targeting Perineural Invasion in Pancreatic CancerIngrid Garajová, Elisa Giovannetti
Current Oncology (Toronto, Ont.)|August 28, 2024
Focus on Pancreatic Cancer MicroenvironmentFabiana Pratticò, Ingrid Garajová
Current Oncology (Toronto, Ont.)|July 28, 2023
Focus on Therapeutic Options for Surgically Resectable Pancreatic Adenocarcinoma Based on Novel BiomarkersAlessandro Olivari, Virginia Agnetti, Ingrid Garajová
Current Pharmaceutical Design|January 20, 2019
Noncoding Rnas Emerging as Novel Biomarkers in Pancreatic CancerIngrid Garajová, Rita Balsano, Chiara Tommasi, et al.
Journal of Clinical Medicine|March 28, 2024
Unraveling the Connection: Pancreatic Cancer Cells and Schwann CellsIngrid Garajová, Francesca Trentini, Francesco Leonardi, et al.
Tumori|October 27, 2022
Olaparib as a single agent treatment in pre-treated metastatic pancreatic cancer patient harboring BRCA2 mutation: What could we expect?Ingrid Garajová, Rita Balsano, Fabio Gelsomino, et al.
Current Oncology (Toronto, Ont.)|November 24, 2023
A Simple Overview of Pancreatic Cancer Treatment for Clinical OncologistsIngrid Garajová, Marianna Peroni, Fabio Gelsomino, et al.
Translational Oncogenomics|December 3, 2015
c-Met as a Target for Personalized TherapyIngrid Garajová, Elisa Giovannetti, Guido Biasco, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Small Bowel Adenocarcinoma: From Molecular Insights to Clinical ManagementFabio Gelsomino, Rita Balsano, Stefania De Lorenzo, et al.
Frontiers in Pharmacology|December 26, 2024
NGF-mediated crosstalk: unraveling the influence of metabolic deregulation on the interplay between neural and pancreatic cancer cells and its impact on patient outcomesFrancesca Trentini, Virginia Agnetti, Martina Manini, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Cancers|January 8, 2025
Targeting Perineural Invasion in Pancreatic CancerIngrid Garajová, Elisa Giovannetti
Current Oncology (Toronto, Ont.)|August 28, 2024
Focus on Pancreatic Cancer MicroenvironmentFabiana Pratticò, Ingrid Garajová
Current Oncology (Toronto, Ont.)|July 28, 2023
Focus on Therapeutic Options for Surgically Resectable Pancreatic Adenocarcinoma Based on Novel BiomarkersAlessandro Olivari, Virginia Agnetti, Ingrid Garajová
Current Pharmaceutical Design|January 20, 2019
Noncoding Rnas Emerging as Novel Biomarkers in Pancreatic CancerIngrid Garajová, Rita Balsano, Chiara Tommasi, et al.
Journal of Clinical Medicine|March 28, 2024
Unraveling the Connection: Pancreatic Cancer Cells and Schwann CellsIngrid Garajová, Francesca Trentini, Francesco Leonardi, et al.
Tumori|October 27, 2022
Olaparib as a single agent treatment in pre-treated metastatic pancreatic cancer patient harboring BRCA2 mutation: What could we expect?Ingrid Garajová, Rita Balsano, Fabio Gelsomino, et al.
Current Oncology (Toronto, Ont.)|November 24, 2023
A Simple Overview of Pancreatic Cancer Treatment for Clinical OncologistsIngrid Garajová, Marianna Peroni, Fabio Gelsomino, et al.
Translational Oncogenomics|December 3, 2015
c-Met as a Target for Personalized TherapyIngrid Garajová, Elisa Giovannetti, Guido Biasco, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Small Bowel Adenocarcinoma: From Molecular Insights to Clinical ManagementFabio Gelsomino, Rita Balsano, Stefania De Lorenzo, et al.
Frontiers in Pharmacology|December 26, 2024
NGF-mediated crosstalk: unraveling the influence of metabolic deregulation on the interplay between neural and pancreatic cancer cells and its impact on patient outcomesFrancesca Trentini, Virginia Agnetti, Martina Manini, et al.
Pageof 4